IV vs Intrathecal Stem Cell Therapy for Autism: How the Routes Differ
Two different delivery routes for mesenchymal stem cell therapy, compared on what they do, when they are considered, and what families should expect.
Mesenchymal stem cell therapy for autism can be delivered through different routes. The two most relevant for autism programs are intravenous (IV) administration and intrathecal administration. These are not competing options — they are different tools used in different clinical situations, sometimes within the same program.
What Each Route Does
[IV administration](/treatments/intravenous-stem-cell-therapy.html) delivers MSCs into the bloodstream. Cells circulate systemically and exert their effects largely through paracrine signaling — releasing anti-inflammatory and immunomodulatory molecules that influence the broader immune environment. This route is the foundation of most autism MSC protocols.
[Intrathecal administration](/treatments/intrathecal-stem-cell-administration.html) delivers MSCs directly into the cerebrospinal fluid via a lumbar puncture. This places signaling activity in much closer proximity to the central nervous system. It is a more invasive procedure and is considered only when clinically appropriate.
When IV Is the Right Starting Point
For most children entering an autism stem cell program, IV is the appropriate starting route. It addresses systemic immune dysregulation and inflammatory signaling, has a well-documented safety profile, can be repeated across treatment cycles, and is generally well tolerated by paediatric patients.
For many families, an IV-led protocol — sometimes combined with [exosome therapy](/exosome-therapy.html) — delivers what the medical team considers the optimal balance of clinical effect and tolerability.
When Intrathecal Is Considered
Intrathecal administration may be considered when the clinical picture suggests a particular need for CNS-proximate signaling, when prior IV cycles have been well tolerated and the family wishes to extend the protocol, or when the medical team and family agree, after full informed consent, that the more invasive route is appropriate.
Intrathecal administration is not a default route. It is selected case-by-case after careful evaluation and is never used to "upsell" a more aggressive program. See [Safety and Eligibility](/safety-eligibility.html) for how candidacy is assessed.
Have Questions About This Approach?
Our team can help you understand whether this treatment path may be appropriate for your child. Request a free consultation to discuss your child's specific needs.
- JCI-aligned clinical standards
- Coordinator response within 24 hours
- No-obligation medical review
Safety Profile
Both routes have well-documented safety profiles in published clinical studies of MSC therapy, with mild transient effects being the most common. The intrathecal route adds the typical considerations of a lumbar puncture procedure — careful monitoring, sterile technique, and short post-procedure observation — and is performed only by qualified physicians in appropriately equipped settings.
How Dose Is Decided
Dose for either route is determined by the medical team based on the child's weight, age, clinical profile, and prior treatments. There is no fixed "autism dose" — protocols are individualised. See [Personalized Treatment Planning](/treatments/personalized-treatment-planning.html) for how this works.
Combined Protocols
Many autism programs use IV as the foundation and add exosome therapy or, where clinically indicated, intrathecal administration. The objective is not to use every available route, but to match the protocol to the child. [Combined stem cell and exosome protocols](/treatments/combined-stem-cell-and-exosome-protocols.html) are the most commonly chosen comprehensive approach.
What Parents Should Ask
- Why is this specific route being recommended for my child?
- What is the published safety profile for this route in paediatric MSC therapy?
- What is the rationale for the dose being proposed?
- What follow-up is included after the procedure?
- Is the same effect achievable with a less invasive route?
How We Decide With You
At Autism Stem Care, the choice between IV, intrathecal, and combined protocols is made after a structured medical review. Most families start with IV-led protocols. Intrathecal is reserved for cases where the medical team believes the benefit clearly outweighs the additional procedural considerations.
To discuss which route may be appropriate for your child, [book a consultation](/book-consultation.html).
Ready to Explore Treatment Options?
Request a free consultation with our medical coordination team. We'll review your child's case and provide personalized guidance.
- JCI-aligned clinical standards
- Coordinator response within 24 hours
- No-obligation medical review